Product Name :
Anti-LEPR/CD295/OBR(Mibavademab Biosimilar) Antibody
Applications:
ELISA,Flow Cyt
Reactivity :
Human LEPR/CD295/OBR
Conjugate:
Unconjugated
Advantages :
High lot-to-lot consistencyIncreased sensitivity and higher affinityAnimal-free production
Description:
| Description: Anti-LEPR/CD295/OBR(Mibavademab Biosimilar) Antibody is a biosimilar antibody directed against Human LEPR/CD295/OBR. | Isotype: Human IgG4 | Conjugate: Unconjugated | Specificity: Human LEPR/CD295/OBR | Clonality: Monoclonal | Purity: Recombinant Expression and Affinity purified | Concentration: 1mg/ml | Formation: Liquid, 10mM PBS (pH 7.5) | Storage: Store at –20 °C, (Avoid freeze/thaw cycles)
Description2 :
Anti-LEPR/CD295/OBR(Mibavademab Biosimilar) Antibody is a biosimilar antibody directed against Human LEPR/CD295/OBR.
Immunogen:
Host :
Isotype:
Human IgG4
Purity :
Recombinant Expression and Affinity purified
Buffer :
Storage :
Function:
ELISA: 1:5000-1:20000Flow Cyt: 1:200-1:1000Other tested applications.{{2272917-13-0} medchemexpress|{2272917-13-0} Protocol|{2272917-13-0} Description|{2272917-13-0} manufacturer} Dilution factors are presented in the form of a range because the optimal dilution is a function of many factors, such as antigen density, permeability, etc.{{2407860-35-7} site|{2407860-35-7} Protocol|{2407860-35-7} In Vitro|{2407860-35-7} manufacturer} The actual dilution used must be determined empirically.PMID:30969639
